08 · Device Clinical Evidence

Clinical Evaluation Reports (CER)

EU MDR/IVDR-compliant CERs and FDA-supportive clinical evaluations. Comprehensive literature search, evidence synthesis, equivalent device analysis, and a benefit-risk determination Notified Bodies and FDA reviewers actually accept.

Timeline: 4–8 weeks · Starter: $15K · Full: from $45K · In-house clinical experts review and sign off
Request a scoped quote
The problem

CER non-conformities are the #1 reason MDR submissions stall

Notified Bodies under EU MDR have raised the bar dramatically since 2021. Generic, template-driven CERs that worked under the old MDD don't pass review today. Notified Bodies issue major non-conformities for inadequate literature search methodology, weak equivalence claims, and benefit-risk reasoning that doesn't engage the actual evidence.

FDA, increasingly, asks for the same rigor in 510(k) and De Novo clinical sections. We build CERs that work for both reviewers, the first time.

What you receive

A defensible CER, end to end

Literature search with PRISMA flow

Pre-registered search protocol, multi-database execution, screening with reproducible exclusion logic, and a PRISMA flow Notified Bodies expect.

Evidence summary tables

Per-study evidence tables: design, population, endpoints, results, and quality appraisal. Stratified by safety, performance, and clinical benefit.

Equivalent device analysis

Technical, biological, and clinical equivalence analysis matched to MDCG 2020-5 guidance. Equivalence-based or own-data justifications, with the rationale to defend either path.

Benefit-risk synthesis & full CER

Final CER document aligned to MEDDEV 2.7/1 rev 4 structure, with explicit benefit-risk reasoning that engages the evidence rather than recites it.

Two ways to start

Pressure-test the evidence, or have us write the full CER

Pick the on-ramp that fits your timeline. Both come with a fixed-fee SOW in 24 hours.

Quick start
Scope assessment

CER scope assessment

$15K fixed fee · 2 weeks

We review your existing CER (or current evidence position) against MDR/MDCG and FDA expectations and tell you what's missing.

You receive
  • 10–15 page gap analysis vs. MDR/MDCG 2020-13
  • Equivalence vs. own-data path recommendation
  • Top non-conformity risks before NB review
  • 1-hour readout call
Best for: Sponsors with an existing CER worried about NB review, or scoping a fresh CER program.
Start here
Full engagement

Full CER

From $45K Class IIa · Class IIb–III from $80K · 4–8 wks

A complete MDR-aligned CER drafted from scratch by senior clinical specialists.

You receive
  • Pre-registered literature search + PRISMA flow
  • Evidence summary tables with quality appraisal
  • Equivalent device or own-data analysis
  • Full CER document aligned to MEDDEV 2.7/1 rev 4
Best for: Device sponsors maintaining MDR/IVDR compliance or supporting marketing claims.
Get the full proposal

CER deadline approaching?

Send your device, indication, and current evidence position. You'll get a fixed-fee proposal back within one business day.